Zinc lozenges proof of effectiveness in common colds "still lacking," researchers say.
This article was originally published in The Tan Sheet
Executive Summary
ZINC LOZENGES EVIDENCE IN TREATING COLDS "STILL LACKING," according to the results of a meta-analysis of six clinical trials of various oral zinc salts lozenges in patients with community acquired colds, Jeffrey Jackson, MD, et al., Madigan Army Medical Center, Tacoma, Wash., conclude in a study published in the Nov. 10 issue of the Archives of Internal Medicine. The meta-analysis was of nine randomized clinical trials identified in a literature review; one that looked at palatability was excluded, as were two that involved test subjects being inoculated with rhinovirus and did not report symptoms at day seven, the data point selected for analysis by Jackson and colleagues.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning